Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Keeping It Independent
Wyffels Hybrids
The Stem Cell Podcast
The Stem Cell Podcast
Beyond the Void: Philosophy & Psychology for the Modern Mind
btv
God's Eye View
Trevor
No Such Thing As A Fish
No Such Thing As A Fish
Flora Funga Podcast
KK the Plant Biologist with a Thirst for Mycology
The European Molecular Biology Laboratory (EMBL) Alumni Chats Series
EMBL Alumni Relations
Retro Radio: Old Time Radio in the Dark
Darren Marlar
NZZ Quantensprung
NZZ
Permaculture P.I.M.P.cast
Permaculture P.I.M.P.cast
Talking Biotech with Dr. Kevin Folta
Kevin Folta
A Scary Home Companion
Nathaniel Hensley
The Conversation Weekly
The Conversation
The Best Biome
Grassland Groupies
Weird & Dead
Amy Atwater and Meaghan Wetherell
What in the world is dyscalculia?
Dr. Honora Wall, Ed.D.
Mr.希爾
Mr.希爾
Hörgang
Springer Medizin Wien/ Martin Krenek-Burger
SunCast
Nico Johnson
Forschung aktuell
Deutschlandfunk
天方烨谈
基因频道
Forschung aktuell
Deutschlandfunk
La Science, CQFD
France Culture
Embedded Insiders
Embedded Computing Design
JAMA Medical News
JAMA Network
Agriculture Today
Kansas State University
Dinosaur George Kids - A Show for Kids Who Love Dinosaurs
Dinosaur George
No Priors: Artificial Intelligence | Technology | Startups
Conviction
Im Gespräch
ORF
Quantum Healthy
Laura Kissmann & Andeea Rae
Trash Talk
The Landfill Group
The 21CD Podcast
The 21CD Podcast
Artificial Intelligence Masterclass
AI Masterclass
After Skool
After Skool
Quazi Johir
Quazi Johir
Bitcoin Takeover Podcast
Vlad Costea
Science
JAMA Network
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." Related Content: Fi...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now PMOS—Will a New Name...
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue i...
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a Different Disease in ...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content: A Rare Ebola Virus Is Spreading in the...
Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Related Content: Hantavir...
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related Content: More Than ...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed." Related Content: Experts Debate How Obesity Should Be Defin...
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?" Related Content: These Blood Tests May Detect Dozen...
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics." Related Content: Weight Loss, A...
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?" Related Content: Could a Common Antidepress...
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring." Related Content: What to Know About Cic...
Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhi...
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer." Related Content: How mRNA Vaccines Could Help Treat Cancer
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking." Related Content: New Hope for Patients...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines." Related Content: What to Know About the New Lipid Guidelines
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern." Related Content: Why the EPA's Reversal ...
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Again...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.